[Azelastine in the treatment of allergic conjunctivitis].
The efficiency of azelastin (eye drops) in allergic conjunctivitis was evaluated. Ophthalmological, specific allergological, bacteriological, and cytological studies were carried out in 3 groups of patients. Group 1 was treated with claritin (orally), group 2 with azelastin (eye drops), and group 3 with both. The treatment was effective in all 3 groups. Regression of the clinical symptoms started earlier in groups 2 and 3 and was observed throughout the entire period of observation.
Vakhabova
N T
NT
Bakhritdinova
F A
FA
D000284:Administration, Oral; D000328:Adult; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017336:Loratadine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009883:Ophthalmic Solutions; D010793:Phthalazines / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D018926:Anti-Allergic Agents; D009883:Ophthalmic Solutions; D010793:Phthalazines; D017336:Loratadine; C020976:azelastine